Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-12An Open-label, Uncontrolled, Multicenter, Multinational Study on the Efficacy and Safety of Administration of Donor Lymphocytes Depleted of Alloreactive T-cells (ATIR), Through the Use of TH9402 and Light Treatment in an ex Vivo Process, in Patients Receiving a CD34-selected Peripheral Blood Stem Cell Graft From a Related, Haploidentical Donor
-
CLINICAL_TRIALS study record update · 2021-01-08Pilot Study of Infusion of Fucosylated Regulatory T Cells to Prevent Graft Versus Host Disease
-
CLINICAL_TRIALS study record update · 2021-01-08EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL
-
CLINICAL_TRIALS study record update · 2020-12-31A Pilot Study of the Effectiveness of Cognitive Training in Preventing Attention Deficits Among Children in Treatment for Cancer
-
CLINICAL_TRIALS study record update · 2020-12-29Study of Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma (CTCL)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-28Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers : a Pilot Study
-
CLINICAL_TRIALS study record update · 2020-12-28A Randomized, Double Blinded Study of Actonel for the Prevention of Bone Loss in Patients Receiving High Dose Corticosteroids for the Treatment of Acute Lymphocytic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
-
CLINICAL_TRIALS study record update · 2020-12-23Use of Endo Bronchial Ultrasound (EBUS) Trans Bronchial Needle Aspiration (TBNA) for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
-
CLINICAL_TRIALS study record update · 2020-12-22Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and II Classical Hodgkin Lymphoma (HL)
-
CLINICAL_TRIALS study record update · 2020-12-17Phase II Study Evaluating the Efficacy of Lenalidomide in Association With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (PCNSL)
-
CLINICAL_TRIALS study record update · 2020-12-09Unrelated or Partially Matched Allogeneic Donor Stem Cells for Lymphoma, Myeloma, and Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2020-11-16Phase II Trial of CC-5013 (Lenalidomide, Revlimid®) in Patients With Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2020-11-16Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Chimeric Anti-CD20 Monoclonal Antibody (Rituximab) for Stage IV Indolent Lymphoma
-
CLINICAL_TRIALS study record update · 2020-11-12A Phase II Study of R-CHOP and Ibritumomab Tiuxetan (Zevalin) for Elderly Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2020-11-04Rehabilitation Needs of the Malaysian Haematological Cancer Survivors Through a Single Centre Experience
-
CLINICAL_TRIALS study record update · 2020-11-02Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
-
CLINICAL_TRIALS study record update · 2020-11-02A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2020-10-30Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
-
CLINICAL_TRIALS study record update · 2020-10-29A Phase II Study of MK-0683 in Patients With Relapsed / Refractory Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) or Mantle Cell Lymphoma (MCL)
-
CLINICAL_TRIALS study record update · 2020-10-28A Phase 2, Open-label, Single-arm, Two-cohort Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Relapsed/Refractory Primary Testicular Lymphoma (PTL)
-
CLINICAL_TRIALS study record update · 2020-10-27Combined Haploidentical-Cord Blood Transplantation for Adults and Children
-
CLINICAL_TRIALS study record update · 2020-10-23A Phase 1 Study of OT-82 in Patients With Relapsed or Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2020-10-19A Phase II Study Of Rituximab-CHOP With Pegylated Liposomal Doxorubicin In Patients Older Than 60 Years Of Age With Untreated Aggressive B-Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2020-10-19A Randomized Phase III Trial Comparing the Combination of Fludarabine, BBR 2778 (Pixantrone) and Rituximab (FP-R) With the Combination of Fludarabine and Rituximab (F-R) in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2020-10-14A Phase II Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma